临床服务

肿瘤个体化用药检测

项目介绍药物基因组学、分子生物学的迅速发展,解决了传统肿瘤治疗模式中存在的药效低、毒副作用强等问题。爱轻欣运用肿瘤基因靶标检测技术,针对患者的疾病特征,精准找到最佳的治疗药物,使患者达到理想治疗效果。肿瘤个体化治疗示意图“As in lung cancer research, the use of genomic information, the overall mutation patterns

哮喘基因检测

项目介绍

药物基因组学、分子生物学的迅速发展,解决了传统肿瘤治疗模式中存在的药效低、毒副作用强等问题。

爱轻欣运用肿瘤基因靶标检测技术,针对患者的疾病特征,精准找到最佳的治疗药物,使患者达到理想治疗效果。


肿瘤个体化治疗示意图

哮喘基因检测


“As in lung cancer research, the use of genomic information, the overall mutation patterns of breast cancer to determine which mutations play a decisive role in the tumorigenesis process, this should also be the future direction of the Breast Cancer Research”

“如同人们在肺癌中所研究的那样,利用基因组信息,研究乳腺癌的整体突变模式,以决定哪些突变在肿瘤发生发展过程中起到决定作用,这也应该是乳腺癌研究的未来方向。”

Sandra M. SwainElected presidentASCO, 2013

49届美国临床肿瘤学会年会(ASCO2013)候任主席 Sandra M. Swain

“ As more driver mutations are identified,we can expect the complexity of overlapping mutations to increase. This multiplexed approach is clearly practicable; the National Cancer Institute-funded Lung Cancer Mutation Consortium is currently conducting stimultaneous genetic testing for 10 oncogenic changes for which there are specific therapies”

“随着更多的驱动基因突变发生,可以预见各种并存突变越来越多,并愈加复杂。多通路、多靶标检测将彰显优势;美国国立卫生院肺癌突变联盟正对治疗密切相关的10种致癌基因进行并行检测。”

临床肿瘤学杂质,201129:1943-45